Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 18951 - 18975 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Copper	Approved Investigational	OBSL1	23363	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of OBSL1 mRNA	2q35	A21749
Copper	Approved Investigational	OCLN	100506658	upregulated	[NSC 689534 binds to Copper] which results in increased expression of OCLN mRNA	5q13.2	A21749
Copper	Approved Investigational	OGFRL1	79627	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of OGFRL1 mRNA	6q13	A21749
Copper	Approved Investigational	OLAH	55301	upregulated	[NSC 689534 binds to Copper] which results in increased expression of OLAH mRNA	10p13	A21749
Copper	Approved Investigational	OPTN	10133	upregulated	[NSC 689534 binds to Copper] which results in increased expression of OPTN mRNA	10p13	A21749
Copper	Approved Investigational	ORC1	4998	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of ORC1 mRNA	1p32.3	A21749
Copper	Approved Investigational	OSCAR	126014	upregulated	[NSC 689534 binds to Copper] which results in increased expression of OSCAR mRNA	19q13.42	A21749
Copper	Approved Investigational	OSER1	51526	upregulated	[NSC 689534 binds to Copper] which results in increased expression of OSER1 mRNA	20q13.12	A21749
Copper	Approved Investigational	OSGIN1	29948	upregulated	[NSC 689534 binds to Copper] which results in increased expression of OSGIN1 mRNA	16q23.3	A21749
Copper	Approved Investigational	OSMR	9180	upregulated	[Disulfiram binds to Copper] which results in increased expression of OSMR mRNA	5p13.1	A21750
Copper	Approved Investigational	OSR2	116039	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of OSR2 mRNA	8q22.2	A21749
Copper	Approved Investigational	OTUD1	220213	upregulated	[NSC 689534 binds to Copper] which results in increased expression of OTUD1 mRNA	10p12.2	A21749
Copper	Approved Investigational	P2RX5	5026	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of P2RX5 mRNA	17p13.2	A21749
Copper	Approved Investigational	P2RY6	5031	upregulated	Copper results in increased expression of P2RY6 mRNA	11q13.4	A21752
Copper	Approved Investigational	P3H3	10536	upregulated	[Disulfiram binds to Copper] which results in increased expression of P3H3 mRNA	12p13.31	A21750
Copper	Approved Investigational	P3H4	10609	upregulated	[Disulfiram binds to Copper] which results in increased expression of P3H4 mRNA	17q21.2	A21750
Copper	Approved Investigational	PABPC1L	80336	upregulated	[NSC 689534 binds to Copper] which results in increased expression of PABPC1L mRNA	20q13.12	A21749
Copper	Approved Investigational	PACSIN3	29763	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of PACSIN3 mRNA	11p11.2	A21749
Copper	Approved Investigational	PAG1	55824	upregulated	[NSC 689534 binds to Copper] which results in increased expression of PAG1 mRNA	8q21.13	A21749
Copper	Approved Investigational	PAGR1	79447	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of PAGR1 mRNA	16p11.2	A21749
Copper	Approved Investigational	PAIP1	10605	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of PAIP1 mRNA	5p12	A21749
Copper	Approved Investigational	PAK1	5058	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of PAK1 mRNA	11q13.5-q14.1	A21749
Copper	Approved Investigational	PALLD	23022	upregulated	[NSC 689534 binds to Copper] which results in increased expression of PALLD mRNA	4q32.3	A21749
Copper	Approved Investigational	PALMD	54873	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of PALMD mRNA	1p21.2	A21749
Copper	Approved Investigational	PANX2	56666	upregulated	[NSC 689534 binds to Copper] which results in increased expression of PANX2 mRNA	22q13.33	A21749

Displaying entries 18951 - 18975 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability